Tibbiyot, ta’lim va innovatsion tadqiqotlar, 2026, т. 2, № 11, с. 129-132
BOLALARDA ATOPIK DERMATITNI DAVOLASHNING ZAMONAVIY USULI
Аннотация · Abstract
The aim of this study was to evaluate the clinical efficacy and safety of Triderm ointment in children with atopic dermatitis complicated by secondary superficial staphyloderma and candidiasis. The study included 60 children aged 7–18 years, who were divided into two groups. Patients in the first group received Travocort and gentamicin ointment twice daily for 14 days, while patients in the second group received Triderm ointment twice daily over the same period. Disease severity was assessed using the SCORAD index, quality of life was evaluated using the Dermatology Life Quality Index (DLQI), and treatment safety was assessed based on the frequency of adverse events. On day 14 of treatment, the SCORAD score decreased from 36±0.5 to 17±0.5 in the first group and from 38±0.5 to 6±0.5 in the second group. The DLQI score decreased from 19.7±1.1 to 7.3±1.7 and from 19.9±1.3 to 3.2±0.12, respectively. In the Triderm group, S. aureus was detected in 4 (10%) cases and Candida in 1 (4%) case. In the comparison group, the corresponding figures were 12 (30%) and 8 (34.7%), respectively.
Сведения · Details
- DOI 10.5281/zenodo.24079963
- Журнал · Journal Tibbiyot, ta’lim va innovatsion tadqiqotlar
- Язык · Language узбекский
- Цитирования (Crossref) · Citations 0